The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer
Clinical trial NCT05496166 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05496166
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2027-08-01
- Enrollment
- 348
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.